MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 468.00
+10.00 (2.18%)
May 5, 2026, 4:30 PM CET
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Apr '17 Apr 30, 2017 | Apr '16 Apr 30, 2016 |
Sweden Revenue | 983.80M | 957.30M | 898.40M | |||||||||
Sweden Revenue Growth | 2.77% | 6.56% | 11.99% | |||||||||
Nordic (ex-Sweden) Revenue | 637.80M | 612.50M | 448.60M | |||||||||
Nordic (ex-Sweden) Revenue Growth | 4.13% | 36.54% | 30.14% | |||||||||
Europe (ex-Nordic) Revenue | 508.90M | 484.60M | 384.70M | |||||||||
Europe (ex-Nordic) Revenue Growth | 5.01% | 25.97% | -2.46% | |||||||||
Rest of the World Revenue | 40.40M | 53.70M | 75.10M | |||||||||
Rest of the World Revenue Growth | -24.77% | -28.49% | 63.26% | |||||||||
Revenue (Other) | 48.20M | 42.80M | 48.90M | |||||||||
Revenue (Total) | 2.22B | 2.15B | 1.86B | |||||||||
Revenue (Total) Growth | 3.17% | 15.91% | 14.94% |
Revenue Breakdown
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Apr '17 Apr 30, 2017 | Apr '16 Apr 30, 2016 |
Assistive Tech Revenue | 1.00B | 981.80M | 767.20M | |||||||||
Assistive Tech Revenue Growth | 2.18% | 27.97% | 29.92% | |||||||||
Medtech Revenue (Post-Q2 2023 Reporting) | 701.00M | 689.60M | 607.70M | |||||||||
Medtech Revenue (Post-Q2 2023 Reporting) Growth | 1.65% | 13.48% | 18.76% | |||||||||
Medtech Revenue (Pre-Q3 2023 Reporting) | 1.70B | 1.67B | 1.37B | |||||||||
Medtech Revenue (Pre-Q3 2023 Reporting) Growth | 1.96% | 21.57% | 24.75% | |||||||||
Specialty Pharma Revenue | 466.60M | 436.60M | 431.80M | |||||||||
Specialty Pharma Revenue Growth | 6.87% | 1.11% | -11.02% | |||||||||
Revenue (Other) | -1.66B | -1.63B | -1.33B | |||||||||
Revenue (Total) | 2.22B | 2.15B | 1.86B | |||||||||
Revenue (Total) Growth | 3.17% | 15.91% | 14.94% |
Revenue Breakdown 2
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Apr '17 Apr 30, 2017 | Apr '16 Apr 30, 2016 |
Pharmaceuticals Revenue | 455.40M | 424.80M | 420.50M | |||||||||
Pharmaceuticals Revenue Growth | 7.20% | 1.02% | -13.64% | |||||||||
Assistive Technology Revenue | 1.00B | 981.30M | 765.90M | |||||||||
Assistive Technology Revenue Growth | 2.20% | 28.12% | 30.17% | |||||||||
Medical Devices Revenue | 316.70M | 320.10M | 322.70M | |||||||||
Medical Devices Revenue Growth | -1.06% | -0.81% | 25.86% | |||||||||
Nutrition & Other Food Revenue | 348.30M | 333.60M | 251.80M | |||||||||
Nutrition & Other Food Revenue Growth | 4.41% | 32.49% | 13.37% | |||||||||
Other Product Revenue | 48.00M | 48.20M | 45.90M | |||||||||
Other Product Revenue Growth | -0.41% | 5.01% | 36.61% | |||||||||
Revenue (Total) | 2.22B | 2.15B | 1.86B | |||||||||
Revenue (Total) Growth | 3.17% | 15.91% | 14.94% |
Adjusted EBITDA
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Apr '17 Apr 30, 2017 | Apr '16 Apr 30, 2016 |
Assistive Tech Adjusted EBITDA | 304.00M | 289.50M | 212.00M | |||||||||
Assistive Tech Adjusted EBITDA Growth | 5.01% | 36.56% | 45.20% | |||||||||
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) | 149.60M | 145.90M | 138.30M | |||||||||
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) Growth | 2.54% | 5.50% | 39.70% | |||||||||
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) | 453.60M | 435.40M | 350.30M | |||||||||
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) Growth | 4.18% | 24.29% | 42.98% | |||||||||
Specialty Pharma Adjusted EBITDA | 57.90M | 45.70M | 59.20M | |||||||||
Specialty Pharma Adjusted EBITDA Growth | 26.70% | -22.80% | -46.18% | |||||||||
Other and Eliminations from Adjusted EBITDA | -27.00M | -24.80M | -21.70M | |||||||||
Operating Income (Other) | -165.00M | -153.40M | -115.50M | |||||||||
Operating Income (Total) | 319.50M | 302.90M | 272.30M | |||||||||
Operating Income (Total) Growth | 5.48% | 11.24% | 19.69% |
EBIT
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Apr '17 Apr 30, 2017 | Apr '16 Apr 30, 2016 |
Assistive Tech Operating Profit | 227.70M | 217.30M | 164.10M | |||||||||
Assistive Tech Operating Profit Growth | 4.79% | 32.42% | 50.55% | |||||||||
Medtech Operating Profit (Post-Q2 2023 Reporting) | 107.00M | 103.20M | 98.70M | |||||||||
Medtech Operating Profit (Post-Q2 2023 Reporting) Growth | 3.68% | 4.56% | 53.02% | |||||||||
Medtech Operating Profit (Pre-Q3 2023 Reporting) | 334.70M | 320.50M | 262.80M | |||||||||
Medtech Operating Profit (Pre-Q3 2023 Reporting) Growth | 4.43% | 21.96% | 51.47% | |||||||||
Specialty Pharma Operating Profit | 13.60M | 9.20M | 33.40M | |||||||||
Specialty Pharma Operating Profit Growth | 47.83% | -72.45% | -59.27% | |||||||||
Other and Eliminations from Operating Profit | -28.90M | -26.80M | -23.90M | |||||||||
Operating Income (Other) | 100.00K | - | - | |||||||||
Operating Income (Total) | 319.50M | 302.90M | 272.30M | |||||||||
Operating Income (Total) Growth | 5.48% | 11.24% | 19.69% |
Updated Apr 29, 2026. Data Source: Fiscal.ai.